Discover 1,431 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Location: Safety Harbor FL, Clearwater FL, Tampa FL, Sarasota FL,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
New
Study of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis
for
Primary Biliary Cholangitis
Location: Lakewood Rch FL, Atlanta GA, Johnson City TN,
Sponsor: Gilead Sciences
Sex: All
Age: 18 - 70+
Code: NCT07841977
Phase 2, Recruiting
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
for
Chronic Myelomonocytic Leukemia,
Location: Tampa FL, Houston TX, Boston MA, Rochester MN,
Sponsor: Solu Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06950034
Phase 1, Recruiting
Prospective Study to Assess a Diagnostic Aid for Cancer
for
Cancer
Location: Tampa FL, Orange City FL, Stuart FL, Jupiter FL,
Sponsor: Harbinger Health
Sex: All
Age: 45+
Code: NCT07046260
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Pembroke Pines FL, Hollywood FL, Savannah GA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Tampa FL, Jacksonville FL, Miami FL, Atlanta GA,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
for
Friedreich's Ataxia
Location: Tampa FL
Sponsor: University of South Florida
Sex: All
Age: 18 - 70+
Code: NCT01921868
Recruiting
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
for
Severe Aplastic Anemia
Location: Tampa FL, Atlanta GA, Birmingham AL, Charlotte NC,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 3 - 70+
Code: NCT06517641
Phase 2, Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
for
NSCLC Stage IV
Location: Tampa FL, Fort Myers FL, Fort Lauderdale FL, Miami FL,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase 3, Recruiting
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
for
Endometrial Cancer
Location: Tampa FL, Orlando FL, Augusta GA, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: Female
Age: 18 - 70
Code: NCT06481592
Phase 2, Recruiting
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer (Adenocarcinoma),
Location: Tampa FL, Myrtle Beach SC, Baltimore MD, Boston MA,
Sponsor: Acerand Therapeutics (Hong Kong) Limited
Sex: Male
Age: 18+
Code: NCT06801236
Phase 1, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Gainesville FL, Savannah GA, Bluffton SC,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
for
Adult Acute Myeloid Leukemia
Location: Tampa FL, Atlanta GA, Cincinnati OH, Cleveland OH,
Sponsor: Priothera SAS
Sex: All
Age: 18 - 70+
Code: NCT05429632
Phase 3, Recruiting
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
for
Solid Tumors
Location: Tampa FL, Jacksonville FL, Spartanburg SC, Durham NC,
Sponsor: ORIC Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05315700
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
for
Solid Tumor
Location: Tampa FL, Augusta GA, Chicago IL, New York NY,
Sponsor: Eisai Inc.
Sex: All
Age: 18+
Code: NCT04300556
Phase 1, Phase 2, Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC